Similar articles

• Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.

  Isoniemi H, Eklund B, Höckerstedt K, Korsbäck C, Salmela K, von Willebrand E, Häyry P, Ahonen J. Isoniemi H, et al. Transplant Proc. 1990 Aug;22(4):1365-6. Transplant Proc. 1990. PMID: 2202111 Clinical Trial. No abstract available.
• A controlled trial of azathioprine in combination with cyclosporine in cadaveric renal transplantation.

  Griffin PJ, Ferguson CJ, Ross WB, Salaman JR. Griffin PJ, et al. Transplant Proc. 1990 Aug;22(4):1369. Transplant Proc. 1990. PMID: 2202112 Clinical Trial. No abstract available.
• Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.

  Fries D, Hiesse C, Charpentier B, Rieu P, Neyrat N, Cantarovich M, Ouziala M, Bellamy J, Benoit G. Fries D, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):1911-4. Transplant Proc. 1987. PMID: 3547895 Clinical Trial. No abstract available.
• Triple therapy.

  Slapak M, Digard N, Wise M, Setakis N. Slapak M, et al. Transplant Proc. 1991 Aug;23(4):2186-8. Transplant Proc. 1991. PMID: 1871837 Review. No abstract available.
• [Treatment of glomerulonephritis].

  Lison AE. Lison AE. Verh Dtsch Ges Inn Med. 1989;95:581-6. Verh Dtsch Ges Inn Med. 1989. PMID: 2690528 Review. German. No abstract available.